[go: up one dir, main page]

HUT61566A - Process for producing 2,2'-o-cyclonucleosides, nucleosides and their analogous compounds - Google Patents

Process for producing 2,2'-o-cyclonucleosides, nucleosides and their analogous compounds

Info

Publication number
HUT61566A
HUT61566A HU9202906A HU290692A HUT61566A HU T61566 A HUT61566 A HU T61566A HU 9202906 A HU9202906 A HU 9202906A HU 290692 A HU290692 A HU 290692A HU T61566 A HUT61566 A HU T61566A
Authority
HU
Hungary
Prior art keywords
producing
cyclonucleosides
nucleosides
nucleoside
analogous compounds
Prior art date
Application number
HU9202906A
Other languages
English (en)
Other versions
HU9202906D0 (en
Inventor
Khashayar Karimian
Original Assignee
Acic Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2012094 external-priority patent/CA2012094C/en
Priority claimed from CA 2012093 external-priority patent/CA2012093C/en
Application filed by Acic Canada Inc filed Critical Acic Canada Inc
Publication of HU9202906D0 publication Critical patent/HU9202906D0/hu
Publication of HUT61566A publication Critical patent/HUT61566A/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU9202906A 1990-03-13 1991-03-13 Process for producing 2,2'-o-cyclonucleosides, nucleosides and their analogous compounds HUT61566A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA 2012094 CA2012094C (en) 1990-03-13 1990-03-13 Process for producing cytarabine and analogues thereof
CA 2012093 CA2012093C (en) 1990-03-13 1990-03-13 Process for producing 2,2'-cyclocytidine and analogues thereof
PCT/CA1991/000077 WO1991013900A1 (en) 1990-03-13 1991-03-13 Process for producing 2,2'-o-cyclonucleosides, nucleosides, and analogs thereof

Publications (2)

Publication Number Publication Date
HU9202906D0 HU9202906D0 (en) 1992-11-30
HUT61566A true HUT61566A (en) 1993-01-28

Family

ID=25674007

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9202906A HUT61566A (en) 1990-03-13 1991-03-13 Process for producing 2,2'-o-cyclonucleosides, nucleosides and their analogous compounds

Country Status (8)

Country Link
US (1) US5610292A (hu)
EP (1) EP0521923B1 (hu)
AT (1) ATE119541T1 (hu)
AU (1) AU7473791A (hu)
BR (1) BR9106158A (hu)
DE (1) DE69108014T2 (hu)
HU (1) HUT61566A (hu)
WO (1) WO1991013900A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0767657A4 (en) * 1994-06-22 1999-01-20 Nexstar Pharmaceuticals Inc NOVEL PROCESS FOR THE PRODUCTION OF KNOWN AND NEW NUCLEOSIDES, MODIFIED IN THE 2 'POSITION BY INTRAMOLECULAR NUCLEOPHILIC DISPLACEMENT
IT1277425B1 (it) 1995-08-03 1997-11-10 Pro Bio Sint Srl Metodo per la preparazione della 1-b-d-arabinofuranosilcitosina
CA2277159A1 (en) 1997-01-08 1998-07-16 Wolfgang Pieken Bioconjugation of macromolecules
US7427678B2 (en) 1998-01-08 2008-09-23 Sigma-Aldrich Co. Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
EP1186612B1 (en) * 2000-04-13 2006-11-29 Mitsui Chemicals, Inc. Process for the preparation of cytidine derivatives
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
AU2003210629A1 (en) 2002-01-23 2003-09-02 Proligo, Llc Methods for the integrated synthesis and purification of oligonucleotides
WO2004058794A1 (en) 2002-12-31 2004-07-15 Proligo Llc Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
EP1668023A1 (de) * 2003-09-12 2006-06-14 Max-Delbrück-Centrum Für Molekulare Medizin B-l-nucleoside und ihre verwendung als pharmazeutische mittel zur behandlung viraler erkrankungen
CN1300326C (zh) * 2004-12-22 2007-02-14 华南理工大学 酶催化制备阿糖胞苷酯的方法
CA2789097C (en) 2005-04-28 2017-02-21 Proteus Digital Health, Inc. Pharma-informatics system
JP2010503710A (ja) 2006-09-18 2010-02-04 ラプトール ファーマシューティカル インコーポレイテッド 受容体関連タンパク質(rap)結合体の投与による肝障害の処置
US8404830B2 (en) 2007-07-17 2013-03-26 Somalogic, Inc. Method for generating aptamers with improved off-rates
EP2265274B1 (en) 2008-03-03 2018-11-21 Tosk, Inc. Methotrexate adjuvants to reduce toxicity and methods for using the same
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
MX2012011771A (es) 2010-04-12 2012-12-17 Somalogic Inc Aptameros para beta-ngf y su uso en el tratamiento de enfermedades y trastornos mediados por beta-ngf.
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP7008405B2 (ja) 2013-11-21 2022-01-25 ソマロジック・インコーポレーテッド シチジン-5-カルボキサミド修飾ヌクレオチド組成物及びそれに関連する方法
US11446303B2 (en) 2019-06-21 2022-09-20 Tosk, Inc. Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
ATE125265T1 (de) * 1990-03-13 1995-08-15 Acic Canada Inc 2,3'-o-cyclocytidine und verfahren zu deren herstellung.

Also Published As

Publication number Publication date
ATE119541T1 (de) 1995-03-15
EP0521923B1 (en) 1995-03-08
WO1991013900A1 (en) 1991-09-19
AU7473791A (en) 1991-10-10
DE69108014D1 (de) 1995-04-13
BR9106158A (pt) 1993-03-16
EP0521923A1 (en) 1993-01-13
US5610292A (en) 1997-03-11
DE69108014T2 (de) 1995-07-06
HU9202906D0 (en) 1992-11-30

Similar Documents

Publication Publication Date Title
HUT61566A (en) Process for producing 2,2'-o-cyclonucleosides, nucleosides and their analogous compounds
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
HUT73655A (en) Process for preparing substituted 1,3-oxathiolanes with antiviral properties
CA2009637A1 (en) Substituted-1,3-oxathiolanes with antiviral properties
HUT48886A (en) Process for producing purinyl- and pirimidinyl-cyclobutans
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
EP0236935A3 (en) Carboxylic purine nucleosides, their production and use
HU893004D0 (en) Process for producing purine derivatives
BG100916A (en) Process for the diastereoselective synthesis of nucleoside analogues
CA2223081A1 (en) Heterocyclic ring-fused pyrimidine derivatives
EP0334368A3 (en) Production of 2',3'-dideoxy-2',3'-didehydronucleosides
YU204888A (en) Process for obtaining 2',3'-dideoxy-2'-fluorine-nucleoside
HUT50820A (en) Process for producing purine derivatives with antiviral effect
DE3264465D1 (en) 7-beta-d-arabinofuranosyl-7h-pyrrolo(2,3-d)pyrimidine-4-amine 5'-phosphate compounds useful as antiviral agents, pharmaceutical compositions containing the compounds, and processes for producing the compounds
ZA915905B (en) Cyclopentane derivatives,process for their production and their pharmaceutical use
EG18301A (en) Process for preparing of 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives
HUT53522A (en) Process for producing pharmaceutical compositions comprising purine derivatives
PT88568A (pt) Process for the preparation of saccharides derivatives
DE69627519D1 (de) Sesquiterpen-derivate mit antiviraler aktivität
CA2012093A1 (en) Process for producing 2,2'-cyclocytidine and analogues thereof
GR3025375T3 (en) Process for preparing AZT and derivatives thereof.
HUT54153A (en) Process for producing purinyl- and pyrimidinyltetrahydrofuran derivatives and pharmaceutical compositions comprising same
CA2012094A1 (en) Process for producing cytarabine and analogues thereof
EP0250755A3 (en) Fluorine derivatives of vitamin d3 and process for producing the same
HUT58103A (en) Process for producing purinyl and pyrimidinyl tetrahydrofuran derivatives and pharmaceutical compositions comprising same

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee